Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
In millions, except per share items | Jun-30-23 | Jun-30-22 | Mar-31-22 | Dec-31-21 | Sep-30-21 | Jun-30-21 | Mar-31-21 | Dec-31-20 |
| 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q | 10-Q | 10-K |
Revenues |
Americas | | 6,602.0 | 6,732.0 | 6,666.0 | 6,592.0 | 6,471.0 | 6,316.0 | 6,255.0 |
EMEA | | 3,468.0 | 3,513.0 | 3,552.0 | 3,352.0 | 3,293.0 | 3,179.0 | 3,195.0 |
APAC | | 2,738.0 | 2,782.0 | 2,803.0 | 2,759.0 | 2,685.0 | 2,574.0 | 2,475.0 |
Medication Delivery | | 2,947.0 | 2,934.0 | 2,880.0 | 2,839.0 | 2,757.0 | 2,665.0 | 2,703.0 |
Other | | 131.0 | 114.0 | 109.0 | 104.0 | 105.0 | 105.0 | 193.0 |
|
EBITDA |
Americas | | 2,479.0 | 2,623.0 | 2,612.0 | 2,570.0 | 2,505.0 | 2,400.0 | 2,345.0 |
EMEA | | 626.0 | 616.0 | 632.0 | 620.0 | 579.0 | 541.0 | 567.0 |
APAC | | 640.0 | 636.0 | 623.0 | 615.0 | 610.0 | 601.0 | 591.0 |
|
EBIT |
Americas | | 2,479.0 | 2,623.0 | 2,612.0 | 2,570.0 | 2,505.0 | 2,400.0 | 2,345.0 |
EMEA | | 626.0 | 616.0 | 632.0 | 620.0 | 579.0 | 541.0 | 567.0 |
APAC | | 640.0 | 636.0 | 623.0 | 615.0 | 610.0 | 601.0 | 591.0 |
|
Mix |
Americas | | 47.0% | 49.7% | 52.1% | 52.9% | 53.1% | 53.4% | 53.6% |
EMEA | | 24.7% | 25.9% | 27.8% | 26.9% | 27.0% | 26.9% | 27.4% |
APAC | | 19.5% | 20.5% | 21.9% | 22.2% | 22.0% | 21.8% | 21.2% |
Medication Delivery | | 21.0% | 21.7% | 22.5% | 22.8% | 22.6% | 22.6% | 23.2% |
Other | | 0.9% | 0.8% | 0.9% | 0.8% | 0.9% | 0.9% | 1.7% |
|
Growth |
Americas | | 2.0% | 6.6% | 6.6% | 2.7% | 2.0% | -1.3% | -0.8% |
EMEA | | 5.3% | 10.5% | 11.2% | 14.3% | 11.9% | 5.4% | 7.6% |
APAC | | 2.0% | 8.1% | 13.3% | 15.3% | 15.0% | 10.6% | 7.6% |
Medication Delivery | | 6.9% | 10.1% | 6.5% | 6.1% | 1.7% | -4.7% | -1.3% |
Other | | 24.8% | 8.6% | -43.5% | -238.7% | 169.2% | -21.6% | 53.2% |
|